Skip to content
Open in App
ABVC Biopharma logo

ABVC Biopharma

web2

ABVC Biopharma is a clinical stage biotechnology company developing investigational medicines a...

Symbol ยท ABVC
Company profile

About

ABVC Biopharma is a clinical stage biotechnology company developing investigational medicines and an ophthalmic medical device for neurological, psychiatric, cancer and eye related conditions. Its development portfolio includes candidate treatments for major depressive disorder and attention deficit hyperactivity disorder, alongside Vitargus, a proposed vitreous substitute for eye surgery. The company licenses technology originating from research institutions and works with development partners on clinical studies and potential commercialization arrangements. Its programs are at different investigational stages and should not be described as broadly approved or commercially marketed therapies. ABVC also holds interests in development related subsidiaries and assets.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeNasdaqPrimary symbol: ABVC
Expert coverage

ABVC Biopharma profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment